Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2012-07-18 Director's Dealing
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2012-07-18 English
BOVIE 8-K RE ANNUAL MEETING 2012
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated July 12, 2012, reporting on the results of the company's annual meeting of stockholders. It details the voting results for the election of directors, approval of a share incentive plan, and ratification of the independent auditors. The content is focused on the official results from shareholder votes at the annual meeting, which matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 3282 characters, which is relatively short but contains detailed voting results, not just an announcement of a report. Therefore, it is not a Report Publication Announcement (RPA). The document is not a full annual report, audit report, or management report, nor is it a proxy solicitation or presentation. Hence, the correct classification is DVA with high confidence.
2012-07-13 English
13G/A
Major Shareholding Notification
2012-07-09 English
PRIMARY DOCUMENT
Director's Dealing
2012-05-22 English
PRIMARY DOCUMENT
Director's Dealing
2012-05-22 English
PRIMARY DOCUMENT
Director's Dealing
2012-05-22 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.